Navigation Links
SARS impact could be devastating

With a severe blow by SARS, the economies of several countries are forecast to shrink in the second quarter. More than five million foreign workers, from Filipina maids to Indonesian laborers and Vietnamese plantation workers, oil the wheels of commerce in the region, sending home in excess of $20 billion each year to their families. Studies show most of those families used the remittances for consumption buying cars and building new houses directly improving standards of living// and boosting their local economies. Among the throng of migrating laborers, an estimated 210,000 Thais left home to work abroad in 2000, as did 416,424 Indians, 376,000 Indonesians, 841,000 Filipinos and 31,000 Vietnamese, according to the most recent United Nations data.

Many of the countries and territories they head for, including Singapore and Hong Kong, are among the hardest hit by SARS, which has killed more than 260 people worldwide and infected some 4,600 since it emerged in China late last year. In Singapore, foreign workers make up 24 percent of the labor force. Seven percent of workers in Hong Kong are foreign. China doesn't take in many foreign workers, but quite large numbers of Chinese go abroad, essentially illegally, to Japan and Taiwan. With the smuggling of Chinese workers into these countries, there is huge potential for spreading the disease. Japan has some 600,000 foreign workers. While SARS so far appeared to be mainly spread by business travellers and holiday-makers, taking a huge toll on the airline and leisure industries, governments also needed to rethink the way they handled migrant workers to prevent them from succumbing to the disease and accelerating its spread.
'"/>




Page: 1

Related medicine news :

1. Double impact vaccine
2. Sex timing has no impact on risk of Birth defects
3. Marriage does not have much impact on life satisfaction
4. Breastfeeding not found to have an impact on weight of the child.
5. Burning energy and its impact on health during exercise can be of genetic origin
6. Womb may have impact upon Blood Pressure
7. Eating together has both psychological and health impacts
8. Even 6 months or more of hormone therapy treatment does not impact longevity of prostate cancer patients
9. Virus Level could Predict Cervical Cancer Risk
10. Beware of the oral patch! It could be cancer!!!
11. Prozac miracle could end in disaster

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: SARS impact could devastating

(Date:11/27/2009)..., NEUILLY-SUR-SEINE,France,Nov.27/PRNewswire/--Te...clingteamdedicatedtoethicalsportinganddevelopingth...atitwillbecomeTeamGarmin-Transitionswiththeadditio...tionsOpticalistheworld,sleadingmanufacturerofadapt...nologyinthewidestselectionofspectaclelensessuchasT...
(Date:11/27/2009)... XenaCare Holdings has announc...thritis Foundation, one of the largest nonprofit o...ublic health education. , ...aCare Holdings, Inc. (OTCBB: XCHO), a company spec...of consumer healthcare products, has announced tod...
(Date:11/27/2009)...ng rates to bring unprecedented medical, economic ... 27 (HealthDay News) -- The number of people with ...e over the next 25 years, a new study predicts. ,...1 million people with the disease, up from 23.7 mi...reating people with diabetes will triple, the stud...
(Date:11/27/2009)... Voyant Health™ announce...an) has licensed its TraumaCad Enterprise orthoped...rkflow solution. , (PRWEB...ced today that Spectrum Health (Grand Rapids, Mich...edic templating solution and its TraumaCad Extend ...
(Date:11/27/2009)... Specialist manufacturers who ...cts are saving millions of dollars by bringing in ...cess. Increasing numbers of pro-active medical man...s at the concept stage of their projects, ensuring... design processes or potentially outdated technolo...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...LLE, Pa., Dec. 21 RESPIRONICS, INC.,(Nasdaq: RES...ve merger,agreement pursuant to which Royal Philip... commence a tender offer to acquire all of the out... a,premium of approximately 31% over Respironics, ...
... study finds that most general surgeons do not dis...breast cancer treatment. The analysis shows that o...or breast conserving surgery have such discussions...nstruction has increased treatment choices for wom...
...Calif., Dec. 20 ISTA Pharmaceuticals,Inc. (Nasdaq...ed a New Drug,Application (NDA) to the U.S. Food a...ce-daily). The Company is seeking approval for Xib...opical non-steroidal anti-inflammatory compound fo...
...om Community Will Fund 20 Percent of Cost for New ...undation announced that it has reached its $50 mil...mportant philanthropic effort Sharp has ever,under...com/cgi-bin/prnh/20071220/DC10448 ), "It,s only ...
...ON, Dec. 20 Today URAC called for,comments on maj...alth Web,Site, HIPAA Privacy (Business Associate a...sociate and Covered Entity) accreditation programs...ne for public comment is Feb. 10, 2008., (LOGO: ...
...N, Va., Dec. 20 MCG Capital,Corporation (Nasdaq: ...ferred,equity investment to support the acquisitio...ld & Lamb is a medical-financial services company ...tion industry,since 2001. Having completed in exce...
Other Medicine News:Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 2Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 3Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 4Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 5Health News:Reconstruction surgery rarely discussed with breast cancer patients 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 3Health News:URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs 2Health News:MCG Capital Invests in Gould & Lamb 2
(Date:11/25/2009)...wire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amed...imallydisruptivesurgicaltreatmentsforthespine,anno...vember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferenc...ntfortheCompany,sproductsandwillincludecommentsfro...n.Thedial-innumbersare1-877-407-4018fordomesticcal...
(Date:11/25/2009)...dJOHANNESBURG,November25/PRNewswire/--,iThembaPhar...cedtoday,thattheyhavesignedacollaborativeagreement...is,sworldclasscomputationalchemistryandleaddiscove...iontoprovidemedicinaland,syntheticchemistrysupport...entnetwork.iThembaPharmaceuticalsandPyxisDiscovery...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2FDA Approves NovoLog 28R 29 Labeling Update 51814 1FDA Approves NovoLog 28R 29 Labeling Update 51814 2FDA Approves NovoLog 28R 29 Labeling Update 51814 3FDA Approves NovoLog 28R 29 Labeling Update 51814 4U S Students Academic Interests Tend to Wane in Middle School 51812 1U S Students Academic Interests Tend to Wane in Middle School 51812 2Michael Steele Chairman of the Republican National Committee Will Hold a Press Conference on Health Care the Republican Alternative at 9 am on Mon 51810 1
...at data,presented recently at the 17th Annual Meet...iology demonstrate that the Genous Bio-engineered ...eluting stents., Presented by Federico Piscione, ...fessor with the Federico II University of Naples,s...dicine and Cardiovascular,Sciences, the data were ...
...ion Application currently u...erapeutics, Inc. (CTI),(Nasdaq: CTIC ; MTA) today...domized phase III trial comparing OPAXIO(TM) (pacl...orelbine for the treatment of PS 2,(performance st...ll cell,lung cancer (NSCLC) in the Journal of Thor...
Other Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5
...ested Timeter® Classic Flowmeters demonstrates...oviders and patients alike. You can see it in the ... can see it in the performance, year after year. E...d and engineered to the highest standards of perfo...
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/Y Bar & 2 Power Take Off
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/T Bar
Soft-Touch Timeter® 8 LPM Flowmeter
Medicine Products: